Risk factors for reported influenza and influenza-like symptoms in patients with rheumatoid arthritis

Scandinavian Journal of Rheumatology

Volumn 41, Issue 5, 2012, Pages 359-365

  Dirven, L ^a   Huizinga, T W J ^a   Allaart, C F ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LEFLUNOMIDE; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; AGE; ARTICLE; BODY MASS; CONTROLLED STUDY; COUGHING; DIARRHEA; DISEASE ACTIVITY; DYSPNEA; EYE REDNESS; FEMALE; FLU LIKE SYNDROME; GENDER; HEADACHE; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAUSEA; PRIORITY JOURNAL; QUESTIONNAIRE; REMISSION; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; RISK FACTOR; SORE THROAT; VOMITING;

ADULT; AGED; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; VACCINATION;

EID: 84867268986     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2012.670729     Document Type: Article

References (20)

1. Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 2002;46:2287-93.
2. Koetz K, Bryl E, Spickschen K, O'Fallon WM, Goronzy JJ, Weyand CM. T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci USA 2000;97:9203-8.
3. Saag KG, Koehnke R, Caldwell JR, Brasington R, Burmeister LF, Zimmerman B, et al. Low dose long-Term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med 1994;96:115-23.
4. SegalBH, SnellerMC. Infectious complications of immunosuppressive therapy in patients with rheumatic diseases. Rheum Dis Clin North Am 1997;23:219-37.
5. Galloway JB,HyrichKL, Mercer LK,DixonWG, FuB,Ustianowski AP, et al. Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly. Rheumatology (Oxford) 2011;50:124-31.
6. Fomin I, Caspi D, Levy V, Varsano N, Shalev Y, Paran D, et al. Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers. Ann Rheum Dis 2006;65:191-4.
7. Gelinck LB, van der Bijl AE, Beyer WE, Visser LG, Huizinga TW, van Hogezand RA, et al. The effect of anti-Tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Ann Rheum Dis 2008;67:713-16.
8. Donker GA. Continuous morbidity registration at Dutch sentinel stations, 2007. Annual Report from the Netherlands Institute for Health Services Research 2008.
9. Hernandez-Cruz B, Cardiel MH, Villa AR, Alcocer-Varela J. Development, recurrence, and severity of infections in Mexican patients with rheumatoid arthritis. A nested case-control study. J Rheumatol 1998;25:1900-7.
10. van der Veen MJ, van der Heide A, Kruize AA, Bijlsma JW. Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate. Ann Rheum Dis 1994;53: 224-8.
11. Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE. Predictors of infection in rheumatoid arthritis. Arthritis Rheum 2002;46:2294-300.
12. Franklin J, Lunt M, Bunn D, Symmons D, Silman A. Risk and predictors of infection leading to hospitalisation in a large primarycare-derived cohort of patients with inflammatory polyarthritis. Ann Rheum Dis 2007;66:308-12.
13. Listing J, Strangfeld A, Kary S, Rau R, von Hinueber U, Stoyanova-Scholz M, et al. Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum 2005;52: 3403-12.
14. St Clair EW, van der Heijde DM, Smolen JS, Maini RN, Bathon JM, Emery P, et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum 2004;50:3432-43.
15. Kapetanovic MC, Saxne T, Nilsson JA, Geborek P. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Rheumatology (Oxford) 2007;46:608-11.
16. Elkayam O, Bashkin A, Mandelboim M, Litinsky I, Comaheshter D, Levartovsky D, et al. The effect of inflixi-mab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum 2010;39:442-7.
17. Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis 2006;6:438-46.
18. Fezeu L, Julia C, Henegar A, Bitu J, Hu FB, Grobbee DE, et al. Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-Analysis. Obes Rev 2011;12:653-9.
19. Barclay S, Todd C, Finlay I, Grande G, Wyatt P. Not another questionnaire! Maximizing the response rate, predicting nonresponse and assessing non-response bias in postal questionnaire studies of GPs. Fam Pract 2002;19:105-11.
20. Heberlein T, Baumgartner R. Factors affecting response rates to mailed questionnaires: a quantitative analysis of the published literature. Am Sociol Rev 1978;43:447-62.